MetaCap

Lucid Diagnostics (LUCD) vs Sensus Healthcare (SRTS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Sensus Healthcare (SRTS) has outperformed Lucid Diagnostics (LUCD) over the past year, losing 43.8% versus a loss of 64.7%. Over five years, SRTS leads with a -63.5% price change compared with -95.6% for LUCD. Lucid Diagnostics is the larger company by market cap ($72.6 million vs $37.2 million), about 2.0 times the size.

Sensus Healthcare converts more of its revenue into profit, with a net margin of -28.1% versus -1232.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LUCD-64.67%SRTS-43.78%
+45%-15%-74%
Nov 21, 20251 yearNov 20, 2026
LUCD-96.04%SRTS-59.28%
+183%+37%-109%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LUCD versus SRTS key metrics
MetricLUCDSRTS
Share price$0.3727$2.26
Market cap$72.57M$37.20M
1-day change-3.52%-4.24%
YTD return-65.81%-43.22%
1-year return-64.67%-43.78%
5-year return-95.58%-63.55%
EPS (TTM)$-0.36$-0.97
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$4.71M$27.48M
Revenue growth (YoY)+8.28%-34.26%
Net income (latest FY)$-58.01M$-7.72M
Gross margin-41.73%43.18%
Operating margin-1054.82%-37.50%
Net margin-1232.68%-28.09%
52-week high$1.63$5.49
52-week low$0.303$2.14
Distance from 52-week high-77.12%-58.83%
Analyst consensusstrong_buynone
Avg. price target upside+973.25%+138.05%
Average volume5.15M208.74K
Shares outstanding194.71M16.46M
Employees8260
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SRTS has outperformed LUCD by 20.9 percentage points over the past year.
  • Sensus Healthcare is more profitable, keeping -28.1 cents of every revenue dollar as net income versus -1232.7 cents for Lucid Diagnostics.
  • Lucid Diagnostics grew revenue faster in its latest fiscal year (+8.28% vs -34.26%).

About Lucid Diagnostics

LUCD stock →

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States.

Health Care · Medical/Dental Instruments · 82 employees

About Sensus Healthcare

SRTS stock →

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.

Health Care · Medical/Dental Instruments · 60 employees

LUCD vs SRTS FAQ

Which is bigger, Lucid Diagnostics or Sensus Healthcare?

Lucid Diagnostics (LUCD) is larger, with a market capitalization of $72.57M compared with $37.20M for Sensus Healthcare (SRTS).

Which stock has performed better over the past year, LUCD or SRTS?

SRTS returned -43.78% over the past 12 months, compared with -64.67% for LUCD (price return, excluding dividends). Past performance does not predict future results.

Are Lucid Diagnostics and Sensus Healthcare in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons